OptiNose Stock (NASDAQ: OPTN) stock price, news, charts, stock research, profile.
Open | $1.07 |
Close | - |
Volume / Avg. | 257.80K / 1.25M |
Day Range | 1.03 - 1.08 |
52 Wk Range | 0.80 - 2.10 |
Market Cap | $120.39M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 7.04% |
Days to Cover | 14.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OptiNose (NASDAQ:OPTN) through any online brokerage.
Other companies in OptiNose’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Telomir Pharmaceuticals (NASDAQ:TELO) and Trevi Therapeutics (NASDAQ:TRVI).
There is no analysis for OptiNose.
OptiNose has a consensus price target of $4.20.
The stock price for OptiNose (NASDAQ: OPTN) is $1.06 last updated July 8, 2024 at 9:19 AM EDT.
There are no upcoming dividends for OptiNose.
OptiNose’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for OptiNose.
OptiNose is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.